Peter Verwilst

Dr. Peter Verwilst

Rega Institute for Medical Research, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2018 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
HJHyo Sung Jung
Hyo Sung Jung
PVPeter Verwilst
Peter Verwilst
ASAmit Sharma
Amit Sharma
JSJinwoo Shin
Jinwoo Shin
JSJonathan Sessler
Jonathan Sessler
Jong Seung KimJong Seung Kim
Jong Seung Kim
Over the last decade, organic photothermal therapy (PTT) agents have attracted increasing attention as a potential complement for, or alternative to, classical drugs and sensitizers involving inorganic nanomaterials.

17 July 2019 in Chemical Reviews
Verified
Journal Article
Closed access
DCDuxia Cao
Duxia Cao
ZLZhiqiang Liu
Zhiqiang Liu
PVPeter Verwilst
Peter Verwilst
SKSeyoung Koo
Seyoung Koo
PJParamesh Jangili
Paramesh Jangili
WLWeiying Lin
Weiying Lin

14 January 2016 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
HJHyo Sung Jung
Hyo Sung Jung
PVPeter Verwilst
Peter Verwilst
WKWon Young Kim
Won Young Kim
Jong Seung KimJong Seung Kim
Jong Seung Kim
Recent advances in the field of fluorescent and colorimetric sensors for water content/humidity are described.

29 February 2024 in Chemical Reviews
Verified
Journal Article
Open access
ASAmit Sharma
Amit Sharma
PVPeter Verwilst
Peter Verwilst
MLMingle Li
Mingle Li
DMDandan Ma
Dandan Ma
NSNem Singh
Nem Singh
Jong Seung KimJong Seung Kim
Jong Seung Kim
The ability to gain spatiotemporal information, and in some cases achieve spatiotemporal control, in the context of drug delivery makes theranostic fluorescent probes an attractive and intensely investigated research topic. This interest is reflected in the steep rise in publications on the topic that have appeared over the past decade. Theranostic fluorescent probes, in their various incarnations, generally comprise a fluorophore linked to a masked drug, in which the drug is released as the result of certain stimuli, with both intrinsic and extrinsic stimuli being reported. This release is then signaled by the emergence of a fluorescent signal. Importantly, the use of appropriate fluorophores has enabled not only this emerging fluorescence as a spatiotemporal marker for drug delivery but also has provided modalities useful in photodynamic, photothermal, and sonodynamic therapeutic applications. In this review we highlight recent work on theranostic fluorescent probes with a particular focus on probes that are activated in tumor microenvironments. We also summarize efforts to develop probes for other applications, such as neurodegenerative diseases and antibacterials. This review celebrates the diversity of designs reported to date, from discrete small-molecule systems to nanomaterials. Our aim is to provide insights into the potential clinical impact of this still-emerging research direction.

23 June 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HJHyo Sung Jung
Hyo Sung Jung
JLJae-Hong Lee
Jae-Hong Lee
KKKyutae Kim
Kyutae Kim
SKSeyoung Koo
Seyoung Koo
PVPeter Verwilst
Peter Verwilst
Jong Seung KimJong Seung Kim
Jong Seung Kim

20 February 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
CDChong Duan
Chong Duan
MWMiae Won
Miae Won
PVPeter Verwilst
Peter Verwilst
JXJunchao Xu
Junchao Xu
HKHyeong Seok Kim
Hyeong Seok Kim
Jong Seung KimJong Seung Kim
Jong Seung Kim